3-Oxoglutaric acid



Compound IDCDAMM00991
Common name3-Oxoglutaric acid
IUPAC name3-oxopentanedioic acid
Molecular formulaC5H6O5

Experimental data

Retention time17.53
Adduct[M+H]+
Actual mz147.03
Theoretical mz147.029
Error2.88
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7351

Identifiers and class information

Inchi keyOXTNCQMOKLOUAM-UHFFFAOYSA-N
SmilesO=C(O)CC(=O)CC(=O)O
SuperclassOrganic acids and derivatives
ClassKeto acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)5
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)2
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)146.099
Computed dipole moment(dipole)8.319
Total solvent accessible surface area (SASA)320.057
Hydrophobic component of SASA (FOSA)86.369
Hydrophilic component of SASA (FISA)233.687
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)489.598
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)4
Free energy of solvation of dipole (dip^2/V)0.141357
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.938637
Predicted polarizability in cubic angstroms (QPpolrz)10.871
Predicted hexadecane/gas partition coefficient (QPlogPC16)4.608
Predicted octanol/gas partition coefficient (QPlogPoct)7.385
Predicted water/gas partition coefficient (QPlogPw)5.136
Predicted octanol/water partition coefficient (QPlogPo/w)-0.045
Predicted aqueous solubility (QPlogS)0.383
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.32
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)1.09
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)3.864
Predicted brain/blood partition coefficient (QPlogBB)-1.446
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.973
Predicted skin permeability, log Kp (QPlogKp)-5.442
PM3 calculated ionization potential (IP(ev))11.199
PM3 calculated electron affinity (EA(eV))0.749
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)-1.523
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)37.19
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)125.502
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P24046GABRR1GABA receptor rho-1 subunitT99665SEA
O75899GABBR2GABA-B receptorT42446SEA
P48066SLC6A11GABA transporter 3T38200SEA
O75899GABBR2GABA-B receptorT42446SEA
Q4U2R8SLC22A6Solute carrier family 22 member 6 (by homology)T70680SwissTargetPrediction and SEA
Q6B0I6KDM4DLysine-specific demethylase 4DT17036SEA
Q9Y4C1KDM3ALysine-specific demethylase 3AT25362SEA
O15054KDM6BLysine-specific demethylase 6BT56057SEA
P04035HMGCRHMG-CoA reductaseT53585SwissTargetPrediction
P41229KDM5CLysine-specific demethylase 5CT85540SEA
Q9Y2K7KDM2ALysine-specific demethylase 2AT71949SEA
Q6ZMT4KDM7ALysine-specific demethylase 7A/7BT18784SEA
Q9UPP1PHF8Histone lysine demethylase PHF8T00933SEA
P28476GABRR2GABA(A) receptor rho2T90682SEA
Q9UN88GABRQGABA(A) receptor thetaT15161SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T42446DI0117Depression[ICD-11: 6A70-6A7Z]O75899GABBR2
T42446DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]O75899GABBR2
T42446DI0275Multiple sclerosis[ICD-11: 8A40]O75899GABBR2
T42446DI0290Narcolepsy[ICD-11: 7A20]O75899GABBR2
T38200DI0207Indeterminate colitis[ICD-11: DD72]P48066SLC6A11
T42446DI0117Depression[ICD-11: 6A70-6A7Z]O75899GABBR2
T42446DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]O75899GABBR2
T42446DI0275Multiple sclerosis[ICD-11: 8A40]O75899GABBR2
T42446DI0290Narcolepsy[ICD-11: 7A20]O75899GABBR2
T70680DI0167Gout[ICD-11: FA25]Q4U2R8SLC22A6
T70680DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]Q4U2R8SLC22A6
T70680DI0310Ocular disease[ICD-11: N.A.]Q4U2R8SLC22A6
T53585DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P04035HMGCR
T53585DI0102Coronary atherosclerosis[ICD-11: BA52]P04035HMGCR
T53585DI0128Dyslipidemia[ICD-11: 5C80-5C81]P04035HMGCR
T53585DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P04035HMGCR
T53585DI0275Multiple sclerosis[ICD-11: 8A40]P04035HMGCR
T53585DI0287Myocardial infarction[ICD-11: BA41-BA43]P04035HMGCR
T53585DI0324Pain[ICD-11: MG30-MG3Z]P04035HMGCR

Copyright © 2025